文献速递妇科

根治性子宫颈切除术治疗早期宫颈癌:系统综述

Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review.
PubMed 文献 · Obstet Gynecol · 2020-01-01

该系统综述检索1990至2019年文献,纳入47篇报道2566例接受根治性阴式、腹式或腹腔镜子宫颈切除术的早期宫颈癌患者,中位随访48个月,中位复发率3.3%,5年无复发生存率94.6%,妊娠率23.9%,活产率75.1%;文献主要为病例报告和病例系列,缺乏可做Meta分析的高级证据。

要点

  • 根治性子宫颈切除术治疗早期宫颈癌的文献主要为病例报告和病例系列。
  • 中位随访48个月,中位复发率3.3%,中位5年无复发生存率94.6%,总生存率97.4%。
  • 术后妊娠率23.9%,活产率75.1%。

核心结论

  • 根治性子宫颈切除术作为宫颈癌保留生育功能的治疗在文献中广泛报道,但发表文献主要限于病例报告和病例系列。
  • 报告的随访时间不常达到标准肿瘤学参数,但无复发生存率、总生存率和妊娠结局令人鼓舞。
  • 缺乏可供Meta分析的高级证据。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和Cochrane Library(包括ClinicalTrials.gov)1990至2019年文献,排除灰色文献和未发表数据。
  • 从合并EndNote库去除重复后,使用Covidence软件审查490篇文章,两名审查者筛选标题和摘要,再筛选全文。
  • 纳入标准为报道根治性子宫颈切除术并以淋巴结评估作为宫颈癌原发治疗、且明确报告随访间隔和复发的文章。
  • 共纳入47篇文章,报道2566例女性。

主要发现

  • 大多数肿瘤为鳞状组织学(68.5%)、IB1期(74.8%)、2 cm或更小(69.2%)、无淋巴血管间隙浸润(68.8%)。
  • 计划行子宫颈切除术者中9%术中转为子宫切除术。
  • 按手术途径分,根治性阴式、腹式和腹腔镜途径分别占58.1%、37.2%和4.7%。
  • 各研究中位随访48个月(范围2-202个月),中位复发率3.3%(范围0-25%),中位复发时间26个月(范围8-44个月)。
  • 中位5年无复发生存率和总生存率分别为94.6%(范围88-97.3%)和97.4%(范围95-99%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 发表文献主要限于病例报告和病例系列。
  • 报告的随访时间不常达到标准肿瘤学参数。
  • 缺乏可供Meta分析的高级证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess surgical, oncologic, and pregnancy outcomes in patients undergoing radical vaginal, abdominal, or laparoscopic trachelectomy for the treatment of early-stage cervical cancer, using a methodic review of published literature. DATA SOURCES: PubMed, EMBASE, and Cochrane Library sources, including ClinicalTrials.gov, were searched from 1990-2019 with terms "cervical cancer" and "(vaginal, abdominal, open, minimally invasive, or laparoscopic) radical trachelectomy." Grey literature and unpublished data were omitted. METHODS OF STUDY SELECTION: After removal of duplicates from a combined EndNote library of results, 490 articles were reviewed using Covidence software. Two reviewers screened titles and abstracts, and then screened full texts. Selection criteria included articles that reported radical trachelectomy with lymph node assessment as primary therapy for cervical carcinoma, with stated follow-up intervals and recurrences. TABULATION, INTEGRATION, AND RESULTS: Variables of interest were manually extracted into an electronic database. A total 47 articles that reported on 2,566 women met inclusion criteria. Most tumors were of squamous histology (68.5%), stage IB1 (74.8%), 2 cm or less (69.2%), and without lymphovascular invasion (68.8%). Of planned trachelectomies, 9% were converted intraoperatively to hysterectomy. Separated by route of trachelectomy, 58.1%, 37.2%, and 4.7% were performed using radical vaginal, abdominal, and laparoscopic approaches, respectively. With median follow-up of 48 months (range 2-202 months) across studies, median recurrence rate was 3.3% (range 0-25%); median time to recurrence was 26 months (range 8-44 months). Median 5-year recurrence-free and overall survival were 94.6% (range 88-97.3%) and 97.4% (range 95-99%), respectively. The posttrachelectomy pregnancy rate was 23.9%, with a live-birth rate of 75.1%. CONCLUSION: Radical trachelectomy for fertility-preserving treatment of cervical cancer is widely reported in the literature, though publications are mainly limited to case reports and case series. Reported follow-up periods infrequently meet standard oncologic parameters but show encouraging recurrence-free and overall survival rates and pregnancy outcomes. Higher-level evidence needed for meta-analysis is lacking. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42019132443.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Smith ES, Moon AS, O'Hanlon R, et al. Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review. Obstet Gynecol. 2020. PMID: 32769648. doi:10.1097/AOG.0000000000003952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。